Immunotherapies: Exploiting the Immune System for Cancer Treatment

Figure 5

Bivalent design and function of anti-MET antibodies and siRNA aptamers. A bivalent anti-MET antibody blocks the HGF ligand from binding to the dimerized MET receptor. This prevents the activation of a multitude of factors required for tumor cell survival, proliferation, and motility.